Número de publicaciones
572
Buscador de publicaciones
  • Losa, F; Iglesias, L; Pane, M; Sanz, J; Nieto, B; Fuste, V; de la Cruz-Merino, L; Concha, A; Balañá C; Matias-Guiu, X

    2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 1361-1372. .

    [doi:10.1007/s12094-018-1899-z]

  • GATIUS, S.

    Ginecología Oncológica. Manual Práctico.

    Ginecología Oncológica. Manual Práctico. 93-100. .

  • Fernandez-de-Misa, Ricardo; Hernandez-Machin, Buenaventura; Combalia, Andrea; Garcia-Muret, MD; Servitje, Octavio; Muniesa, Cristina; Gallardo, Fernando; Rujol, RM; Marti, RM; Ortiz-Brugues, Ariadna; Maronas-Jimenez, Lidia; Ortiz-Romero, PL; Blanch-Rius, Laura; Roman, Concepcion; Canueto, Javier; Mar, Blanes; Bastida, Jesus; Morillo, Mercedes; Penate, Yeray; Gala, SP; Molins, Marta; Lara, PE; Gil, AP; Estrach, Teresa

    Primary cutaneous anaplastic large cell lymphoma (pcALCL): Initial approach and long-term follow-up in 108 patients.

    EUROPEAN JOURNAL OF CANCER 101 19-20. .

    [doi:10.1016/j.ejca.2018.07.257]

  • Moiola, CP; Lopez-Gil, C; Cabrera, S; Garcia, A; Van Nyen, Tom; Annibali, D; Fonnes, T; Vidal, A; Villanueva, A; Matias-Guiu, X; Krakstad, C; Amant, F; Gil-Moreno, A; Colas, E

    Patient-Derived Xenograft Models for Endometrial Cancer Research

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19 -. .

    [doi:10.3390/ijms19082431]

  • Van Nyen, T; Moiola, CP; Colas, E; Annibali, D; Amant, F

    Modeling Endometrial Cancer: Past, Present, and Future

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 19 -. .

    [doi:10.3390/ijms19082348]

  • Garrido, Pilar; Aldaz, Azucena; Calleja, Miguel Angel; de Alava, Enrique; Lamas, Maria Jesus; Martin, Miguel; Matias-Guiu, Xavier; Palacios, Jose; Vera, Ruth

    Propuesta para la creación de una Estrategia Nacional sobre Medicina de Precisión en Cáncer: posicionamiento de la SEOM, SEAP y SEFH.

    REVISTA ESPANOLA DE PATOLOGIA 51 154-159. .

    [doi:10.1016/j.patol.2017.10.003]

  • Maiques, O; Barcelo, C; Panosa, A; Pijuan, J; Orgaz, JL; Rodriguez-Hernandez, I; Matas-Nadal, C; Tell, G; Vilella, R; Fabra, A; S P; Sanz-Moreno, V; Matias-Guiu, X; Canti, C; Herreros, J; Marti, RM; Macia, A

    T-type calcium channels drive migration/invasion in BRAFV600E melanoma cells through Snail1

    PIGMENT CELL & MELANOMA RESEARCH 31 484-495. .

    [doi:10.1111/pcmr.12690]

  • Fernandez Armenteros, Jose Manuel; Arco Huguet, Nuria; Sanmartin Novell, Veronica; Vilardell Villellas, Felip; Velasco Sanchez, Ana; Martro Catala, Elisa; Marti Laborda, Rosa Maria; Soria Gili, Xavier

    Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series

    PEDIATRIC BLOOD & CANCER 65 -. .

    [doi:10.1002/pbc.27047]

  • Goebel, EA; Vidal, A; Matias-Guiu, X; Blake Gilks C

    The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

    VIRCHOWS ARCHIV 472 885-896. .

    [doi:10.1007/s00428-017-2279-8]

  • Cortes, C; Bielsa, S; Fernandez, JM; Vilardell, F; Gonzalez-Farre, B; Casanova, JM

    Extensive Nasal Plaque: An Unusual Presentation of IgG4-related Disease

    ACTA DERMATO-VENEREOLOGICA 98 606-607. .

    [doi:10.2340/00015555-2917]

  • Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, C; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J

    Early evolutionary divergence between papillary and anaplastic thyroid cancers

    ANNALS OF ONCOLOGY 29 1454-1460. .

    [doi:10.1093/annonc/mdy123]

  • Romero, I; Rubio, MJ; Medina, M; Serrano, R; Guerra, EM; Salgado, AC; Perez, B; Minig, L; Casado, A; Coronado, P; Cueva, JF; Vilar, A; Torne, A; Ordi, J; Cros, S; Salinas, G; Santacana, M; Schoenenberger-Arnaiz, JA; Llombart-Cussac, A; Poveda, A

    Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study).

    Journal of Clinical Oncology 36 5598-5598. .

    [doi:10.1200/JCO.2018.36.15_suppl.5598]